Eli Lilly's Ozempic-rivaling weight-loss pill orforglipron could be available in early 2026. Its retatrutide may be as ...

Detailed price information for Novo Nordisk A/S ADR (NVO-N) from The Globe and Mail including charting and trades.

One of Novo Nordisk's next-generation obesity shots to follow up on the success of Wegovy helped patients lose 22% of their ...

Novo Nordisk's experimental obesity drug, amycretin, displayed impressive results, causing a 22% weight loss in participants over 36 weeks. The news boosted Novo’s shares and highlights its potential ...

One of Novo Nordisk's next-generation obesity shots to follow up on its success with Wegovy helped patients lose 22% of their ...

Anti-obesity drug Mounjaro is set to rack up global sales worth nearly £22bn a year by the end of the decade. But Donald ...

Wegovy is a GLP-1 agonist containing semaglutide, the same active ingredient as Ozempic. While both medications share this ...

Hairdresser Joshua Hilton, 30, from Wiltshire, weighed 20 stone (127kg) and felt so unhealthy, he began avoiding his friends ...

Frozen’s Josh Gad shared insight into his weight loss journey after losing 40 pounds with the help of medication.

NPA chairman Nick Kaye told the PA news agency that while obesity is "one of the biggest challenges facing" the UK, they are ...

Mounjaro can make hormonal birth control pills less effective. Your doctor may recommend that you use a different birth control method or use a barrier method, such as a condom, along with your ...

Wall Street investors, spurred on by Trump's pro-business agenda, could be ignoring real risks posed by the president.